Venus Medtech (Hangzhou) Inc.
VMTHF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $788 | $35 | $34 | $34 |
| - Cash | $279 | $298 | $486 | $774 |
| + Debt | $494 | $369 | $498 | $826 |
| Enterprise Value | $1,003 | $106 | $47 | $85 |
| Revenue | $187 | $240 | $231 | $236 |
| % Growth | -22.1% | 4.1% | -2.1% | – |
| Gross Profit | $138 | $186 | $182 | $188 |
| % Margin | 73.7% | 77.5% | 78.8% | 79.7% |
| EBITDA | -$122 | -$450 | -$163 | -$209 |
| % Margin | -65.3% | -187.5% | -70.5% | -88.5% |
| Net Income | -$135 | -$508 | -$206 | -$354 |
| % Margin | -72% | -211.5% | -89.5% | -150% |
| EPS Diluted | -0.31 | -1.16 | -0.47 | -0.81 |
| % Growth | 73.3% | -146.8% | 42% | – |
| Operating Cash Flow | $0 | -$59 | $82 | -$279 |
| Capital Expenditures | $0 | $2 | -$44 | -$207 |
| Free Cash Flow | $0 | -$57 | $39 | -$486 |